Deans' stroke musings: Association of poor subjective sleep quality with risk for death by suicide during a 10-year period: a longitudinal, population-based study of late life

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, August 19, 2014

Association of poor subjective sleep quality with risk for death by suicide during a 10-year period: a longitudinal, population-based study of late life

Is your doctor doing anything about your sleep problems other than having nurses hand out sleeping pills every night while in the hospital?
http://www.mdlinx.com/internal-medicine/newsl-article.cfm/5481324/ZZF307965849E94474BB34FC062CEC0F93/?
Older adults have high rates of sleep disturbance, die by suicide at disproportionately higher rates compared with other age groups, and tend to visit their physician in the weeks preceding suicide death. To authors' knowledge, to date, no study has examined disturbed sleep as an independent risk factor for late–life suicide. To examine the relative independent risk for suicide associated with poor subjective sleep quality in a population–based study of older adults during a 10–year observation period. The results indicate that poor subjective sleep quality is associated with increased risk for death by suicide 10 years later, even after adjustment for depressive symptoms. Disturbed sleep appears to confer considerable risk, independent of depressed mood, for the most severe suicidal behaviors and may warrant inclusion in suicide risk assessment frameworks to enhance detection of risk and intervention opportunity in late life.
Methods

A longitudinal case–control cohort study of late–life suicide among a multisite, population–based community sample of older adults participating in the Established Populations for Epidemiologic Studies of the Elderly.
Of 14 456 community older adults sampled, 400 control subjects were matched (on age, sex, and study site) to 20 suicide decedents.
Primary measures included the Sleep Quality Index, the Center for Epidemiologic Studies–Depression Scale, and vital statistics.

Results

Hierarchical logistic regressions revealed that poor sleep quality at baseline was significantly associated with increased risk for suicide (odds ratio [OR], 1.39; 95% CI, 1.14–1.69; P < .001) by 10 follow–up years.
In addition, 2 sleep items were individually associated with elevated risk for suicide at 10–year follow–up: difficulty falling asleep (OR, 2.24; 95% CI, 1.27–3.93; P < .01) and nonrestorative sleep (OR, 2.17; 95% CI, 1.28–3.67; P < .01).
Controlling for depressive symptoms, baseline self–reported sleep quality was associated with increased risk for death by suicide (OR, 1.30; 95% CI, 1.04–1.63; P < .05)